Risperidone-SABER®
| Disease area studied | Abbreviated title | Phase | Study ID | Registry database | Study results | Plain language summary | Publication (if available) |
|---|---|---|---|---|---|---|---|
| Schizophrenia | A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia | Phase 1 |
ZX003-1101
Completed |
NCT01592110 | |||
| Schizophrenia | Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia | Phase 1 |
ZX003-1401
Completed |
NCT02411526 |